Order Article Reprints

Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F, et al. Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. International Journal of Molecular Sciences. 2022; 23(14):7898. https://doi.org/10.3390/ijms23147898

Ecke, Thorsten H., Paula Carolin Voß, Thorsten Schlomm, Anja Rabien, Frank Friedersdorff, Dimitri Barski, Thomas Otto, Michael Waldner, Elke Veltrup, Friederike Linden, and et al. 2022. "Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment" International Journal of Molecular Sciences 23, no. 14: 7898. https://doi.org/10.3390/ijms23147898

Ecke, T. H., Voß, P. C., Schlomm, T., Rabien, A., Friedersdorff, F., Barski, D., Otto, T., Waldner, M., Veltrup, E., Linden, F., Hake, R., Eidt, S., Roggisch, J., Heidenreich, A., Rieger, C., Kastner, L., Hallmann, S., Koch, S., & Wirtz, R. M. (2022). Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. International Journal of Molecular Sciences, 23(14), 7898. https://doi.org/10.3390/ijms23147898